Section: 
Science articles
Science articlesNon-surgical treatment of infant’s subglottic hemangiomas
M. L. Zakharova (1), P. V. Pavlov (1), K. K. Rachkova (1)
(1) Saint Petersburg State Pediatric Medical University, Saint Petersburg, 194100, Russia
UDK: 616.22-006.311.03-053.2-085:615.217.22
DOI: https://doi.org/10.18692/1810-4800-2016-6-49-54
ABSTRACT
The objective of the study: to analyse the experience of non-surgical treatment of infant’s subglottic hemangiomas using non-selective β blocker propranolol. The results: At the period of 2011 through 2016 seven children, diagnosed with congenital disorder – the infant’s subglottic hemangioma – were observed in Otorhinolaryngology Clinic of Saint Petersburg State Pediatric Medical University. All of them were treated with glucocorticosteroids as a starting therapy. Propranolol therapy started immediately after diagnostics and consultation of a cardiologist and vascular surgeon. Persistent hemangioma regress and the absence of larynx stenosis symptoms were registered in all the patients. The observation period constituted 6 months through 4 years. Propranolol therapy duration was determined individually: 1 year through 2 years. No side effects from propranolol administration have been observed. Conclusion: We consider that Propranolol can be recommended as a basic therapy of infant`s subglottic hemangiomas together with a short course of glucocorticosteroids as a starting therapy.
Publication date:
01.12.2016
Keywords:
Propranolol, infant`s subglottic hemangioma, airway, betablocker, glucocorticosteroids For citation:
Zakharova M. L., Pavlov P. V., Rachkova K. K. Non-surgical treatment of infant’s subglottic hemangiomas. Rossiiskaya otorinolaringologiya. 2016;6:49-54. https://doi.org/10.18692/1810-4800-2016-6-49-54